Coated oral 5‐aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease
- 1 February 1990
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 4 (1) , 55-64
- https://doi.org/10.1111/j.1365-2036.1990.tb00449.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Diet Counselling Improves the Clinical Course of Patients with Crohn’s DiseaseDigestion, 1988
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- Importance of Laboratory Parameters in the Evaluation of Crohnʼs Disease ActivityJournal of Clinical Gastroenterology, 1986
- Effect of Ensure®, a Defined Formula Diet, in Patients with Crohn’s DiseaseDigestion, 1986
- Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease.Gut, 1985
- Elemental diet as primary treatment of acute Crohn's disease: a controlled trial.BMJ, 1984
- Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's DiseaseNew England Journal of Medicine, 1980
- Circulating levels of sulphasalazine and its metabolites and their relation to the clinical efficacy of the drug in ulcerative colitis.Gut, 1980
- A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphasalazine (Salazopyrin)Gut, 1973
- Controlled trial of sulphasalazine in the treatment of ulcerative colitisGut, 1964